ストックスクリーナーアプリを入手
6.99
0.14%
0.00
アフターアワーズ：
6.99
前日終値:
$6.99
開ける：
$6.99
24時間の取引高:
361.49K
Relative Volume:
0.19
時価総額：
$573.54M
収益：
$414.29M
当期純損益:
$-99.81M
株価収益率:
-5.2367
EPS:
-1.3348
ネットキャッシュフロー:
$-28.65M
1週間 パフォーマンス:
+0.14%
1か月 パフォーマンス:
+0.43%
6か月 パフォーマンス:
+85.68%
1年 パフォーマンス:
-27.08%
1日の値動き範囲:
$6.99
$7.00
1週間の範囲:
$6.98
$7.00
52週間の値動き範囲:
$3.08
$9.67
Accolade Inc Stock (ACCD) Company Profile
名前
Accolade Inc
セクター
電話
610-834-2989
住所
660 W. GERMANTOWN PIKE SUITE 500, PLYMOUTH MEETING
ACCD を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ACCD
Accolade Inc
|
6.99 | 573.54M | 414.29M | -99.81M | -28.65M | -1.3348 |
|
VEEV
Veeva Systems Inc
|
226.50 | 37.08B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
57.95 | 10.64B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
49.89 | 8.13B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
88.74 | 7.54B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.33 | 6.36B | 906.14M | -52.62M | 89.62M | -0.3621 |
Accolade Inc Stock (ACCD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-06-28 | 繰り返されました | Needham | Buy |
| 2024-02-26 | 開始されました | Leerink Partners | Outperform |
| 2024-01-17 | 再開されました | DA Davidson | Neutral |
| 2024-01-03 | 開始されました | Barclays | Equal Weight |
| 2023-05-24 | アップグレード | BofA Securities | Neutral → Buy |
| 2023-04-12 | 開始されました | Stephens | Overweight |
| 2023-03-23 | アップグレード | Guggenheim | Neutral → Buy |
| 2023-02-09 | ダウングレード | Jefferies | Buy → Hold |
| 2023-02-02 | 開始されました | Raymond James | Outperform |
| 2022-09-08 | 再開されました | Piper Sandler | Overweight |
| 2022-09-07 | 開始されました | Truist | Buy |
| 2022-08-12 | 開始されました | DA Davidson | Buy |
| 2022-05-02 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2022-04-29 | ダウングレード | BTIG Research | Buy → Neutral |
| 2022-04-29 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-04-29 | ダウングレード | Credit Suisse | Outperform → Neutral |
| 2022-04-29 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2022-04-29 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-11 | 開始されました | Wells Fargo | Underweight |
| 2022-04-07 | 開始されました | Guggenheim | Neutral |
| 2022-04-01 | 再開されました | Credit Suisse | Outperform |
| 2022-02-11 | 開始されました | Goldman | Buy |
| 2021-12-02 | 開始されました | Jefferies | Buy |
| 2021-09-30 | 開始されました | Berenberg | Buy |
| 2021-09-17 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2021-05-28 | 開始されました | Robert W. Baird | Neutral |
| 2021-05-06 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2021-04-15 | 開始されました | Needham | Buy |
| 2021-03-11 | 再開されました | Goldman | Buy |
| 2021-01-15 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2021-01-07 | 開始されました | BTIG Research | Buy |
| 2020-12-08 | 開始されました | Canaccord Genuity | Buy |
| 2020-09-22 | 開始されました | DA Davidson | Buy |
| 2020-07-27 | 開始されました | BofA Securities | Buy |
| 2020-07-27 | 開始されました | Credit Suisse | Neutral |
| 2020-07-27 | 開始されました | Goldman | Buy |
| 2020-07-27 | 開始されました | Morgan Stanley | Overweight |
| 2020-07-27 | 開始されました | Piper Sandler | Overweight |
| 2020-07-27 | 開始されました | Robert W. Baird | Outperform |
| 2020-07-27 | 開始されました | SVB Leerink | Outperform |
すべてを表示
Accolade Inc (ACCD) 最新ニュース
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Accolade, Inc. (ACCD) - ACCESS Newswire
Is Accolade Inc. (NASDAQ:ACCD) the Best Performing Stock So Far In 2025? - MSN
Accolade, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Accolade (ACCD) - ACCESS Newswire
Accolade shareholders approve merger with Transcarent By Investing.com - Investing.com South Africa
Accolade Stockholders Approve Merger with Transcarent - TipRanks
Accolade Shareholders Greenlight Merger With Transcarent - MarketScreener
Accolade shareholders approve merger with Transcarent - Investing.com India
Accolade Stockholders Approve Merger Between Accolade and Transcarent - GlobeNewswire
Major Healthcare Deal: Accolade Shareholders Green-Light Transcarent Merger as Company Plans Private Future - Stock Titan
GLAZER CAPITAL, LLC Acquires Significant Stake in Accolade Inc - GuruFocus
Accolade president Robert Cavanaugh sells $1,264 in stock By Investing.com - Investing.com Australia
Accolade CFO Stephen H. Barnes sells $991 worth of stock By Investing.com - Investing.com Australia
Accolade CEO Rajeev Singh sells $2,018 in stock By Investing.com - Investing.com Australia
Accolade president Robert Cavanaugh sells $1,264 in stock - Investing.com India
Accolade CEO Rajeev Singh sells $2,018 in stock - Investing.com India
Accolade CFO Stephen H. Barnes sells $991 worth of stock - Investing.com
STOCKHOLDER ALERT: The M&A Class Action Firm Encourages Shareholders of ACCD, SKGR, AVAV, WMPN to Act Now - The Malaysian Reserve
Do Options Traders Know Something About Accolade (ACCD) Stock We Don't? - Barchart
AcCOLADE CFO Stephen Barnes sells $1,769 in stock By Investing.com - Investing.com Canada
Accolade Inc Stock: $621M Transcarent Buyout Sends Shares Soaring - sharewise
Accolade president Robert Cavanaugh sells shares worth $1,734 By Investing.com - Investing.com Canada
$HAREHOLDER ALERT: The M&A Class Action Firm Urges Stockholders of ACCD, SKGR, AVAV, WMPN to Act Now - GlobeNewswire Inc.
AcCOLADE CFO Stephen Barnes sells $1,769 in stock - Investing.com India
Accolade president Robert Cavanaugh sells shares worth $1,734 - Investing.com
Accolade Being Investigated on Behalf of Accolade, Inc. Investors. Contact Levi & Korsinsky For Details. - ACCESS Newswire
Accolade, Inc. (NASDAQ:ACCD) Stake Boosted by Rhumbline Advisers - Defense World
Analysts Set Accolade, Inc. (NASDAQ:ACCD) Target Price at $6.51 - Defense World
Accolade (NASDAQ:ACCD) Cut to “Hold” at Piper Sandler - Defense World
Accolade Welcomes Oshi Health to Trusted Partner Ecosystem – Company Announcement - Financial Times
Can This Virtual GI Care Partnership Solve the $136B Digestive Health Crisis? - Stock Titan
Accolade president Robert Cavanaugh sells $3,828 in stock - Investing.com Australia
Accolade CEO Rajeev Singh sells $7,802 in company stock By Investing.com - Investing.com Australia
Accolade’s CFO sells $3,577 in stock to cover tax obligations By Investing.com - Investing.com South Africa
Accolade EVP Richard Eskew sells $2,623 in company stock By Investing.com - Investing.com Australia
Accolade CEO Rajeev Singh sells $7,802 in company stock - Investing.com India
Accolade president Robert Cavanaugh sells $3,828 in stock By Investing.com - Investing.com South Africa
Piper Sandler downgrades Accolade ahead of shareholder vote - Investing.com
Accolade EVP Richard Eskew sells $2,623 in company stock - Investing.com
Piper Sandler downgrades Accolade ahead of shareholder vote By Investing.com - Investing.com South Africa
Piper Sandler Downgrades Accolade to Neutral From Overweight, $9 Price Target -March 05, 2025 at 07:54 am EST - Marketscreener.com
Accolade’s CFO sells $3,577 in stock to cover tax obligations - Investing.com
Accolade, Crowdstrike, Marriott International - TradingView
Piper Sandler Downgrades Accolade Inc. (ACCD) to Neutral - StreetInsider
Has Accolade (ACCD) Outpaced Other Business Services Stocks This Year? - Yahoo Finance
Accolade Inc (ACCD) 財務データ
収益
当期純利益
現金流量
EPS
Accolade Inc (ACCD) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Barnes Stephen H. | Chief Financial Officer |
Mar 17 '25 |
Option Exercise |
0.00 |
415 |
0 |
304,176 |
| Barnes Stephen H. | Chief Financial Officer |
Mar 18 '25 |
Sale |
6.99 |
142 |
992 |
304,034 |
| Cavanaugh Robert N | President |
Mar 17 '25 |
Option Exercise |
0.00 |
510 |
0 |
218,878 |
| Cavanaugh Robert N | President |
Mar 18 '25 |
Sale |
6.99 |
181 |
1,264 |
218,697 |
0.54%
2.27%
大文字化:
|
ボリューム (24 時間):